HuagongsheHuagongshe Chemistry Print Report · For research reference only
(R)-2-methoxy-4-(4-methyl-2-oxooxazolidin-3-yl)benzoic acid → (R)-3-{4-[4-(3,5-dimethylpyridin-2-yl)piperazine-1-carbonyl]-3-methoxyphenyl}-4-methyloxazolidin-2-one hydrochloride
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | (R)-2-methoxy-4-(4-methyl-2-oxooxazolidin-3-yl)benzoic acid | HCID 58484787 | — |
| Reactant | 1-(3,5-Dimethylpyridin-2-yl)piperazine hydrochloride | HCID 67381379 | — |
| Product | (R)-3-{4-[4-(3,5-dimethylpyridin-2-yl)piperazine-1-carbonyl]-3-methoxyphenyl}-4-methyloxazolidin-2-one hydrochloride | HCID 67381134 | 37.8% |
Reaction Steps
By reaction and treatment in the same manner as in Example 87 and using (R)-2-methoxy-4-(4-methyl-2-oxooxazolidin-3-yl)benzoic acid (1.1 g) described in Preparation Example 45 and 1-(3,5-dimethylpyridin-2-yl)piperazine hydrochloride (956 mg) described in Preparation Example 64, the title compound (731 mg) was obtained.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08354401B2 |
| Source dataset | uspto-grants-2013_01 |
| ORD ID | ord-5121c145ef64449aa36863d5d889b4ac |
| Source note | uspto-grants-2013_01 |